MDR1 and CYP3A4 polymorphisms among African, Indian, and white populations in KwaZulu-Natal, South Africa

被引：19

作者：

Chelule, PK ^{[1
]}

Gordon, M ^{[1
]}

Palanee, T ^{[1
]}

Page, T ^{[1
]}

Mosam, A ^{[1
]}

Derm, FC ^{[1
]}

Coovadia, HM ^{[1
]}

Cassol, S ^{[1
]}

机构：

[1] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Africa Ctr Hlth & Populat Studies, HIV 1 Mol Virol & Bioinformat Lab, ZA-4001 Durban, South Africa

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2003年 / 74卷 / 02期

关键词：

D O I：

10.1016/S0009-9236(03)00151-6

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：195 / 196

页数：2

共 5 条

[1] MDR1 pharmacogenetics:: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity [J].

Ameyaw, MM ;

Regateiro, F ;

Li, T ;

Liu, XH ;

Tariq, M ;

Mobarek, A ;

Thornton, N ;

Folayan, GO ;

Githang'a, J ;

Indalo, A ;

Ofori-Adjei, D ;

Price-Evans, DA ;

McLeod, HL .

PHARMACOGENETICS, 2001, 11 (03) :217-221

[2]

Cavalli SA, 2001, CLIN CHEM, V47, P348

[3] Identification of functionally variant MDR1 alleles among European Americans and African Americans [J].

Kim, RB ;

Leake, BF ;

Choo, EF ;

Dresser, GK ;

Kubba, SV ;

Schwarz, UI ;

Taylor, A ;

Xie, HG ;

McKinsey, J ;

Zhou, S ;

Lan, LB ;

Schuetz, JD ;

Schuetz, EG ;

Wilkinson, GR .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 70 (02) :189-199

[4] Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P-glycoprotein [J].

Kurata, Y ;

Ieiri, I ;

Kimura, M ;

Morita, T ;

Irie, S ;

Urae, A ;

Ohdo, S ;

Ohtani, H ;

Sawada, Y ;

Higuchi, S ;

Otsubo, K .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 72 (02) :209-219

[5] CYP3A activity in African American and European American men:: Population differences and functional effect of the CYP3A4*1B 5′-promoter region polymorphism [J].

Wandel, C ;

Witte, JS ;

Hall, JM ;

Stein, CM ;

Wood, AJJ ;

Wilkinson, GR .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 68 (01) :82-+

← 1 →